STRUCTURE AND FUNCTION OF THE HIGH AFFINITY IGE RECEPTOR
高亲和力 IGE 受体的结构和功能
基本信息
- 批准号:2886907
- 负责人:
- 金额:$ 12.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-08-01 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The high-affinity receptor (Fc epsilon RI) specific for immunoglobulin E
(IgE) is found primarily on mast cells and basophils. Activation of these
cells occurs in response to crosslinking of Fc epsilon RI with IgE-antigen
complexes which initiates a cascade of cellular events culminating in the
release of pharmacologically active substances that contribute to the
clinical symptoms of many atopic disorders such as allergy, allergic
asthma and immediate hypersensitivity. In this research program the
structural features of Fc epsilon RI that contribute to specific receptor
function will be explored. One goal is to define the molecular features
of the Fc epsilon RI alpha-subunit involved in IgE binding. This will be
approached using the dual approach of (i) protein engineering studies
using both domain and point mutagenesis procedures and (ii) structure
elucidation studies to be conducted initially using nuclear magnetic
resonance spectroscopy in a collaborative study with Dr. A. Bax, National
Institutes of Health. A parallel, but longer-term goal, is to generate
receptor fragment crystals suitable for eventual crystallographic studies.
Protein engineering studies will extensively utilize the powerful
technique of phage display together with bacterial expression of Fc
epsilon RI alpha fragments with subsequent physical characterization of
ligand-binding activity. A long-term goal of this study is the precise
definition of the 3-dimensional configuration of a "minimum complex" of Fc
epsilon RI alpha-IgE. An additional but lower priority aim of this
Proposal is to characterize the rat alpha-subunit ectodomain through
detailed protein engineering studies, with the eventual goal of
elucidating the 3-dimensional structure of this IgE-binding molecule. The
requirement for Fc epsilon RI beta and/or gamma-subunit coexpression for
rat-human alpha-chain ectodomain chimera will be explored as a means of
probing the presumptive extracellular interaction of the receptor
subunits. Progress in all of these studies should assist in the rational
design of potential therapeutics for the treatment of atopic disorders.
In addition, results should facilitate molecular studies of other
immunologically important receptors [such as Fc gamma R] which are
expected to share significant structural features with the IgE mast cell
receptor.
免疫球蛋白E特异性高亲和受体(Fc epsilon RI)
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activati
单克隆抗 Fc ε RI α 链受体抗体抑制 IgE 致敏细胞抗原诱导的介质释放:对近膜 α 链区域参与 Fc ε RI 介导的细胞激活的影响
- DOI:10.4049/jimmunol.166.10.5979
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Nechansky,A;Robertson,MW;Albrecht,BA;Apgar,JR;Kricek,F
- 通讯作者:Kricek,F
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL W ROBERTSON其他文献
MICHAEL W ROBERTSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL W ROBERTSON', 18)}}的其他基金
GENETICS OF PATENT FORAMEN OVALE&ATRIAL SEPTAL ANEURYSM:EVAL MUTATION NKX2-5GENE
卵圆孔未闭的遗传学
- 批准号:
7377824 - 财政年份:2006
- 资助金额:
$ 12.25万 - 项目类别:
GENETICS OF PATENT FORAMEN OVALE&ATRIAL SEPTAL ANEURYSM:EVAL MUTATION NKX2-5GENE
卵圆孔未闭的遗传学
- 批准号:
7200600 - 财政年份:2005
- 资助金额:
$ 12.25万 - 项目类别:
Recombinant human IL-12 for the Rx of Relapsed lymphoma & Hodgkins Disease
重组人 IL-12 用于治疗复发性淋巴瘤
- 批准号:
7045154 - 财政年份:2003
- 资助金额:
$ 12.25万 - 项目类别:
CELLULAR ASSEMBLY AND TRANSPORT OF THE IGE RECEPTOR
IGE 受体的细胞组装和运输
- 批准号:
6475540 - 财政年份:2000
- 资助金额:
$ 12.25万 - 项目类别:
CELLULAR ASSEMBLY AND TRANSPORT OF THE IGE RECEPTOR
IGE 受体的细胞组装和运输
- 批准号:
6624555 - 财政年份:2000
- 资助金额:
$ 12.25万 - 项目类别:
CELLULAR ASSEMBLY AND TRANSPORT OF THE IGE RECEPTOR
IGE 受体的细胞组装和运输
- 批准号:
6266155 - 财政年份:2000
- 资助金额:
$ 12.25万 - 项目类别:
CELLULAR ASSEMBLY AND TRANSPORT OF THE IGE RECEPTOR
IGE 受体的细胞组装和运输
- 批准号:
6682317 - 财政年份:2000
- 资助金额:
$ 12.25万 - 项目类别:
STRUCTURE AND FUNCTION OF THE HIGH AFFINITY IGE RECEPTOR
高亲和力 IGE 受体的结构和功能
- 批准号:
2071666 - 财政年份:1995
- 资助金额:
$ 12.25万 - 项目类别:
STRUCTURE AND FUNCTION OF THE HIGH AFFINITY IGE RECEPTOR
高亲和力 IGE 受体的结构和功能
- 批准号:
2071665 - 财政年份:1995
- 资助金额:
$ 12.25万 - 项目类别:
相似海外基金
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
$ 12.25万 - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10312411 - 财政年份:2021
- 资助金额:
$ 12.25万 - 项目类别:
Increasing efficiency in formation of chimeric proteins
提高嵌合蛋白形成的效率
- 批准号:
561998-2021 - 财政年份:2021
- 资助金额:
$ 12.25万 - 项目类别:
University Undergraduate Student Research Awards
Decoration and Dimerization of Chimeric Proteins Mediated by Coiled-Coil Interactions
卷曲螺旋相互作用介导的嵌合蛋白的修饰和二聚化
- 批准号:
537306-2018 - 财政年份:2019
- 资助金额:
$ 12.25万 - 项目类别:
Collaborative Research and Development Grants
Exploring the therapeutic potential of chimeric proteins
探索嵌合蛋白的治疗潜力
- 批准号:
1947736 - 财政年份:2017
- 资助金额:
$ 12.25万 - 项目类别:
Studentship
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8364271 - 财政年份:2011
- 资助金额:
$ 12.25万 - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8444422 - 财政年份:2010
- 资助金额:
$ 12.25万 - 项目类别:
Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy
猫过敏原-人Fc-gamma1嵌合蛋白治疗猫过敏
- 批准号:
7907314 - 财政年份:2010
- 资助金额:
$ 12.25万 - 项目类别:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
- 批准号:
8171849 - 财政年份:2010
- 资助金额:
$ 12.25万 - 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
- 批准号:
8313432 - 财政年份:2010
- 资助金额:
$ 12.25万 - 项目类别: